3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
5
Rhabdoid Tumor
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Neuroblastoma
5
Medulloblastoma
5
Lymphoma, Non-Hodgkin
5
Histiocytosis, Langerhans-Cell
5
Hepatoblastoma
5
Glioma
5
Ependymoma
5
Sarcoma
4
Rhabdomyosarcoma
4
Osteosarcoma
4
Central Nervous System Neoplasms
4
Sarcoma, Ewing
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroendocrine Tumors
2
Lung Neoplasms
2
Burkitt Lymphoma
2
Xanthogranuloma, Juvenile
1
Pancreatic Neoplasms
1
Pancreatic Intraductal Neoplasms
1
Non functioning pancreatic endocrine tumor
1
Neoplasm Metastasis
1
Lymphoma, B-Cell
1
Lymphoma
1
Histiocytic Sarcoma
1
Familial ependymoma
1
Carcinoma, Non-Small-Cell Lung
1
Adenoma, Islet Cell
1
Interventions
pembrolizumab
37
Paclitaxel
36
Carboplatin
31
Cyclophosphamide
22
Albumin-Bound Paclitaxel
20
atezolizumab
16
130-nm albumin-bound paclitaxel
16
Taxes
15
Doxorubicin
15
Cisplatin
13
Capecitabine
13
Nivolumab
10
Docetaxel
8
olaparib
7
Gemcitabine
6
Everolimus
6
talazoparib
5
durvalumab
5
Magnetic Resonance Spectroscopy
5
Biopsy
5
Bevacizumab
5
veliparib
4
spartalizumab
4
sacituzumab govitecan
4
pegfilgrastim
4
liposomal doxorubicin
4
eribulin
4
Specimen Handling
4
Immunoglobulin G
4
trilaciclib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Triple Negative Breast Neoplasms
×
Phantoms, Imaging
×
Clear all
No trials found.